It sure lifts question marks for the long-acting GLP-1 class on thyroid c-cell hyperplasia and pancreatitis and so indeed lowering the risk for Byetta LAR.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.